NCT06227455

Brief Summary

The goal of this clinical trial is comparing the efficacy of custom-made zirconia sheet versus Polytetrafluoroethylene as a non-resorbable barrier in maxillary alveolar ridge augmentation. The main question it aims to answer are:

  • Participants will be selected according to the inclusion criteria of the study, having a defect in the upper jaw that prevent rehabilitation of the jaw.
  • Participant will undergo a surgical procedure for placement of bone graft and the non-resorbable membrane. Researchers will compare between two groups which differ only in the used membrane. a group where the researchers will place custom made zirconia sheet versus a group where the researchers will place Polytetrafluoroethylene.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

January 18, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 26, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

November 27, 2024

Status Verified

November 1, 2024

Enrollment Period

1.5 years

First QC Date

January 18, 2024

Last Update Submit

November 24, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Bone volume in cubic millimeters

    Volume of the gained bone is assessed by cone-beam computed tomography (CBCT)

    First postoperative week

  • Bone volume in cubic millimeters

    Volume of the gained bone is assessed by cone-beam computed tomography (CBCT)

    Sixth postoperative month

Secondary Outcomes (1)

  • Clinical examination

    Sixth postoperative months

Study Arms (2)

Ti PTFE

SHAM COMPARATOR

TI PTFE is pre-bent and adapted over a 3D printed model for the alveolar defect area after virtual augmentation then used intra-operative over the mixture of Autogenous and xenograft particles.

Procedure: Maxillary alveolar ridge augmentation

Customized zirconia Barrier

ACTIVE COMPARATOR

After virtual augmentation of the defect area, a customized 3D zirconia barrier is designed on a specialized software (Autodesk Meshmixer). The exported STL file of the designed barrier is milled and sterilized. Intra-operatively, the initial try-in of the zirconia barrier is done to allow for adjustment and ensuring a proper fit and tension-free primary closure.

Procedure: Maxillary alveolar ridge augmentation

Interventions

The surgical procedure involves careful flap reflection, autogenous graft harvesting, and placement and fixation of the barriers over mixture of Autogenous graft and xenograft particles.

Customized zirconia BarrierTi PTFE

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients should be free from any relevant systemic disease that would contraindicate surgical intervention or affect bone healing.
  • Patients with single or multiple missing teeth with vertical alveolar defect or severe horizontal defect or both types of defects, preventing placement of any implant or prosthetic appliance in maxilla.
  • Clinically apparent increase in interarch space relative to the adjacent alveolar teeth.

You may not qualify if:

  • History of uncontrolled medical disorders.
  • History of systemic diseases or medication that alter bone metabolism.
  • Poor oral hygiene.
  • Heavy smoker (more than ten cigarettes/day) or alcoholic patients.
  • Chemotherapy or Radiation therapy to the head and neck region in the 12 months prior to the proposed therapy.
  • Patients currently on or with a history of bisphosphonate therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University

Al Mansurah, Addakahlyia, 35516, Egypt

Location

Related Publications (1)

  • Sakr MI, Salem AS, Yaseen AA, Tawfik MA, Mansour NA. Early postoperative evaluation of an open-source digital workflow for designing custom-made zirconia membranes in maxillary guided bone regeneration. BMC Oral Health. 2025 Jul 18;25(1):1200. doi: 10.1186/s12903-025-06592-0.

MeSH Terms

Conditions

Alveolar Bone Loss

Interventions

Alveolar Ridge Augmentation

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Oral Surgical Procedures, PreprostheticOral Surgical ProceduresSurgical Procedures, OperativeDentistry

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 18, 2024

First Posted

January 26, 2024

Study Start

February 1, 2023

Primary Completion

August 1, 2024

Study Completion

November 1, 2024

Last Updated

November 27, 2024

Record last verified: 2024-11

Locations